The PRISTINE registry of MedAlliance Inc.’s SELUTION SLR sirolimus-eluting balloon for below-the-knee artery disease has begun in Singapore, the Swiss company announced on 12 October.
PRISTINE is a 75-patient, single-center registry at the Singapore General Hospital that is evaluating SELUTION SLR in the treatment of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?